REPLIMUNE GROUP, INC. Net Income
REPLIMUNE GROUP, INC. (REPL) reported Net Income of -$69.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$69.77M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$73.18M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$70.93M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$83.10M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for fiscal 2023 was -$174.28M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for fiscal 2022 was -$118.04M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for fiscal 2021 was -$80.87M.
- REPLIMUNE GROUP, INC. net income (loss) attributable to parent for fiscal 2020 was -$52.63M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$69.77M 10-Q · filed 2026-08-14 | -$142.94M derived: sum of 2 quarters · filed 2026-08-14 | -$213.87M derived: sum of 3 quarters · filed 2026-08-14 | -$296.97M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$73.18M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-07-29 | -$144.11M derived: sum of 2 quarters · filed 2026-07-29 | -$227.21M derived: sum of 3 quarters · filed 2026-07-29 | -$313.90M DEF 14A · filed 2026-07-29 | -$313.94M 10-K · filed 2026-06-29 |
| 2025-12-31 | -$70.93M 10-Q · filed 2026-02-03 | -$154.03M derived: sum of 2 quarters · filed 2026-02-03 | -$240.72M 10-Q · filed 2026-02-03 | -$314.86M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-09-30 | -$83.10M 10-Q · filed 2026-02-03 | -$169.79M 10-Q · filed 2025-11-06 | -$243.93M derived: sum of 3 quarters · filed 2026-08-14 | -$310.27M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$86.69M 10-Q · filed 2026-08-14 | -$160.83M derived: sum of 2 quarters · filed 2026-08-14 | -$227.17M derived: sum of 3 quarters · filed 2026-08-14 | -$280.22M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$74.13M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-07-29 | -$140.47M derived: sum of 2 quarters · filed 2026-07-29 | -$193.53M derived: sum of 3 quarters · filed 2026-07-29 | -$247.30M DEF 14A · filed 2026-07-29 | -$247.30M 10-K · filed 2025-05-22 |
| 2024-12-31 | -$66.34M 10-Q · filed 2026-02-03 | -$119.39M derived: sum of 2 quarters · filed 2026-02-03 | -$173.17M 10-Q · filed 2026-02-03 | -$228.25M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2024-09-30 | -$53.05M 10-Q · filed 2026-02-03 | -$106.83M 10-Q · filed 2025-11-06 | -$161.91M derived: sum of 3 quarters · filed 2026-07-29 | -$213.03M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2024-06-30 | -$53.77M 10-Q · filed 2026-02-03 | -$108.85M derived: sum of 2 quarters · filed 2026-07-29 | -$159.97M derived: sum of 3 quarters · filed 2026-07-29 | -$220.02M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2024-03-31 | -$55.08M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-07-29 | -$106.20M derived: sum of 2 quarters · filed 2026-07-29 | -$166.25M derived: sum of 3 quarters · filed 2026-07-29 | -$215.80M DEF 14A · filed 2026-07-29 | -$215.79M 10-K · filed 2024-05-16 |
| 2023-12-31 | -$51.12M 10-Q · filed 2025-02-12 | -$111.16M derived: sum of 2 quarters · filed 2025-02-12 | -$160.72M 10-Q · filed 2025-02-12 | -$209.96M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-09-30 | -$60.04M 10-Q · filed 2025-02-12 | -$109.60M 10-Q · filed 2024-11-12 | -$158.84M derived: sum of 3 quarters · filed 2025-02-12 | -$198.53M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | -$49.55M 10-Q · filed 2025-02-12 | -$98.79M derived: sum of 2 quarters · filed 2025-02-12 | -$138.48M derived: sum of 3 quarters · filed 2025-02-12 | -$181.59M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | -$49.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | -$88.93M derived: sum of 2 quarters · filed 2024-05-16 | -$132.03M derived: sum of 3 quarters · filed 2024-05-16 | -$174.28M 10-K · filed 2024-05-16 | |
| 2022-12-31 | -$39.69M 10-Q · filed 2024-02-08 | -$82.79M derived: sum of 2 quarters · filed 2024-02-08 | -$125.05M 10-Q · filed 2024-02-08 | -$156.74M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-09-30 | -$43.10M 10-Q · filed 2024-02-08 | -$85.36M 10-Q · filed 2023-11-07 | -$117.05M derived: sum of 3 quarters · filed 2024-02-08 | -$146.72M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-06-30 | -$42.25M 10-Q · filed 2024-02-08 | -$73.95M derived: sum of 2 quarters · filed 2024-02-08 | -$103.62M derived: sum of 3 quarters · filed 2024-02-08 | -$132.98M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-03-31 | -$31.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | -$61.37M derived: sum of 2 quarters · filed 2023-05-18 | -$90.72M derived: sum of 3 quarters · filed 2023-05-18 | -$118.04M 10-K · filed 2023-05-18 | |
| 2021-12-31 | -$29.67M 10-Q · filed 2023-02-09 | -$59.03M derived: sum of 2 quarters · filed 2023-02-09 | -$86.34M 10-Q · filed 2023-02-09 | -$107.84M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-09-30 | -$29.36M 10-Q · filed 2023-02-09 | -$56.67M 10-Q · filed 2022-11-03 | -$78.17M derived: sum of 3 quarters · filed 2023-02-09 | -$99.95M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-06-30 | -$27.31M 10-Q · filed 2023-02-09 | -$48.81M derived: sum of 2 quarters · filed 2023-02-09 | -$70.59M derived: sum of 3 quarters · filed 2023-02-09 | -$90.69M derived: sum of 4 quarters · filed 2023-02-09 | |
| 2021-03-31 | -$21.50M 10-K · filed 2021-05-20 | -$43.28M derived: sum of 2 quarters · filed 2022-02-03 | -$63.38M derived: sum of 3 quarters · filed 2022-02-03 | -$80.87M 10-K · filed 2022-05-19 | |
| 2020-12-31 | -$21.78M 10-Q · filed 2022-02-03 | -$41.88M derived: sum of 2 quarters · filed 2022-02-03 | -$59.37M 10-Q · filed 2022-02-03 | -$75.16M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-09-30 | -$20.09M 10-Q · filed 2022-02-03 | -$37.59M 10-Q · filed 2021-11-04 | -$53.38M derived: sum of 3 quarters · filed 2022-02-03 | -$69.57M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | -$17.49M 10-Q · filed 2022-02-03 | -$33.28M derived: sum of 2 quarters · filed 2022-02-03 | -$49.47M derived: sum of 3 quarters · filed 2022-02-03 | -$60.61M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | -$15.79M 10-K · filed 2021-05-20 | -$31.98M derived: sum of 2 quarters · filed 2021-05-20 | -$43.12M derived: sum of 3 quarters · filed 2021-05-20 | -$52.63M 10-K · filed 2021-05-20 | |
| 2019-12-31 | -$16.19M 10-K · filed 2021-05-20 | -$27.33M derived: sum of 2 quarters · filed 2021-05-20 | -$36.84M 10-Q · filed 2021-02-04 | -$43.49M derived: sum of 4 quarters · filed 2021-05-20 | |
| 2019-09-30 | -$11.14M 10-K · filed 2021-05-20 | -$20.65M 10-Q · filed 2020-11-05 | -$27.30M derived: sum of 3 quarters · filed 2021-05-20 | -$34.98M derived: sum of 4 quarters · filed 2021-05-20 | |
| 2019-06-30 | -$9.51M 10-K · filed 2021-05-20 | -$16.16M derived: sum of 2 quarters · filed 2021-05-20 | -$23.84M derived: sum of 3 quarters · filed 2021-05-20 | -$30.30M derived: sum of 4 quarters · filed 2021-05-20 | |
| 2019-03-31 | -$6.66M 10-K · filed 2020-06-03 | -$14.33M derived: sum of 2 quarters · filed 2020-06-03 | -$20.79M derived: sum of 3 quarters · filed 2020-06-03 | -$30.83M 10-K · filed 2020-06-03 | |
| 2018-12-31 | -$7.67M 10-K · filed 2020-06-03 | -$14.13M derived: sum of 2 quarters · filed 2020-06-03 | -$24.18M 10-Q · filed 2020-02-13 | -$31.31M derived: sum of 4 quarters · filed 2020-06-03 | |
| 2018-09-30 | -$6.46M 10-K · filed 2020-06-03 | -$16.50M 10-Q · filed 2019-11-12 | -$23.64M derived: sum of 3 quarters · filed 2020-06-03 | -$28.00M derived: sum of 4 quarters · filed 2020-06-03 | |
| 2018-06-30 | -$10.04M 10-K · filed 2020-06-03 | -$17.18M derived: sum of 2 quarters · filed 2020-06-03 | -$21.53M derived: sum of 3 quarters · filed 2020-06-03 | -$26.19M derived: sum of 4 quarters · filed 2020-06-03 | |
| 2018-03-31 | -$7.14M 10-K · filed 2019-06-28 | -$11.49M derived: sum of 2 quarters · filed 2019-06-28 | -$16.15M derived: sum of 3 quarters · filed 2019-06-28 | -$19.70M 10-K · filed 2020-06-03 | |
| 2017-12-31 | -$4.35M 10-K · filed 2019-06-28 | -$9.01M derived: sum of 2 quarters · filed 2019-06-28 | -$12.85M 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | -$4.66M 10-K · filed 2019-06-28 | -$8.21M 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | -$3.55M 10-K · filed 2019-06-28 | ||||
| 2017-03-31 | -$7.70M 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |